CHRS Coherus Biosciences Inc

在31/12/2022結束的金融年度: Coherus Biosciences Inc的營收decreased by 35.37% ，達到 211.04M。淨利decreased by 1.62%至-291.75M。淨資產decreased by 240.62%到-137.42M；每股盈餘從-3.81increased到-3.76。